Rohan Seth Net Worth

The estimated Net Worth of Rohan Seth is at least $272 Thousand dollars as of 14 December 2021. Mr Seth owns over 1,174 units of Cutera Inc stock worth over $8,486 and over the last 4 years he sold CUTR stock worth over $0. In addition, he makes $263,895 as Chief Financial Officer at Cutera Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr Seth CUTR stock SEC Form 4 insiders trading

Mr has made over 2 trades of the Cutera Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 1,174 units of CUTR stock worth $41,536 on 14 December 2021.

The largest trade he's ever made was buying 1,174 units of Cutera Inc stock on 14 December 2021 worth over $41,536. On average, Mr trades about 99 units every 1 days since 2020. As of 14 December 2021 he still owns at least 12,299 units of Cutera Inc stock.

You can see the complete history of Mr Seth stock trades at the bottom of the page.

Mr. Rohan Seth biography

Rohan Seth is the Chief Financial Officer at Cutera Inc.

What is the salary of Mr Seth?

As the Chief Financial Officer of Cutera Inc, the total compensation of Mr Seth at Cutera Inc is $263,895. There are 3 executives at Cutera Inc getting paid more, with David Mowry having the highest compensation of $3,154,020.

How old is Mr Seth?

Mr Seth is 43, he's been the Chief Financial Officer of Cutera Inc since . There are 10 older and no younger executives at Cutera Inc. The oldest executive at Cutera Inc is Timothy O'Shea, 67, who is the Independent Director.

What's Mr Seth's mailing address?

Rohan's mailing address filed with the SEC is C/O CUTERA, INC., 3240 BAYSHORE BLVD., BRISBANE, CA, 94005.

Insiders trading at Cutera Inc

Over the last 21 years, insiders at Cutera Inc have traded over $58,122,420 worth of Cutera Inc stock and bought 1,064,292 units worth $26,108,997 . The most active insiders traders include Kevin P Connors, J Daniel Plants, and David A Gollnick. On average, Cutera Inc executives and independent directors trade stock every 22 days with the average trade being worth of $13,243. The most recent stock trade was executed by Michael Karavitis on 14 May 2024, trading 63,603 units of CUTR stock currently worth $165,368.

What does Cutera Inc do?

cutera was established in the san francisco bay area (brisbane) in 1998 by veteran laser and optical engineers. as the pioneer of nd:yag technology, cutera® is the trusted authority in face + body energy-based medical aesthetic technologies that practitioners around-the-world turn to for innovation, sophistication and performance. at cutera, we’re always looking forward; developing new solutions, products and industry-leading services designed around the needs of medical aesthetic community—delivering better results, faster and safer than ever before. cutera’s premium portfolio of products include: xeo®, trusculpt® and excel v™. in 2014, cutera introduced two new exciting additions to their family of premium products: excel hr™ for high-speed, comfortable, hair removal and enlighten™, the industry’s first picosecond + nanosecond + 2 wavelength high-powered laser system. today, our worldwide presence is represented in 40 countries, with direct operations in north america, france, austra

Complete history of Mr Seth stock trades at Cutera Inc

Cutera Inc executives and stock owners

Cutera Inc executives and other stock owners filed with the SEC include:

• David Mowry,
  Chief Executive Officer, Director
• R. Jason Richey,
  President
• David H. Mowry,
  CEO & Director
• Rohan Seth,
  Chief Financial Officer
• Gregory Barrett,
  Independent Director
• J. Daniel Plants,
  Independent Chairman of the Board
• Timothy O'Shea,
  Independent Director
• Joseph Whitters,
  Independent Director
• Katherine Zanotti,
  Independent Director
• J. Daniel Plants,
  Exec. Chairman
• Anne Werdan,
  Director - Investor Relations
• Darren Alch,
  Vice President, General Counsel, Secretary
• Rohan Seth,
  Chief Financial Officer
• Dr. Michael Karavitis,
  Exec. VP & Chief Technology Officer
• Jerry P Widman,
  Director
• Miguel Pardos,
  EVP, International Sales
• James A. Reinstein,
  President and CEO
• Clinton Severson,
  Director
• David B Apfelberg,
  Director
• Larry Laber,
  EVP, North America Sales
• Kevin P Connors,
  President and CEO
• David A Gollnick,
  VP of Research and Development
• Thomas John Liolios,
  VP of International
• Keith J Sullivan,
  Director
• Nicholas Sheridan Lewin,
  Director
• Sandra A. Gardiner,
  EVP & Chief Financial Officer
• Elisha W Finney,
  Director
• Guy P Nohra,
  Director
• Michael J Levernier,
  VP of Clinical Development
• Associates Iii Lp Medventure,
  10% owner
• Guy Palta California Partne...,
  
• Kathleen A Maynor,
  VP of Regulary Affairs & QA
• Associates Management Iii C...,
  10% owner
• Guy Palta Partnersalta Cali...,
  
• Dean Macfarland,
  
• Michael W Sasnett,
  
• W Mark Lortz,
  Director
• Leonard C De Benedictis,
  Chief Technology Officer
• White Annette Campbell,
  Director
• Robert John Jr Shine,
  VP of International
• Ronald J Santilli,
  CFO & VP of Finance and Admin.
• John Connors,
  VP of North American Sales
• Jeryl L Hilleman,
  Director
• Michael Karavitis,
  EVP, Chief Technology Officer
• Sheila Hopkins,
  Director
• Juliane Park,
  Director
• Janet D. Widmann,
  Director
• Kevin J Cameron,
  Director
• Stuart Drummond,
  Interim CFO
• Taylor C. Harris,
  Chief Executive Officer
• Jeffrey S Jones,
  Chief Operating Officer
• Stephana Eilene Patton,
  Chief Legal Officer